Homologous Recombination and Its Role in Carcinogenesis
- PMID: 12488587
- PMCID: PMC153790
- DOI: 10.1155/S1110724302204052
Homologous Recombination and Its Role in Carcinogenesis
Abstract
Cancer develops when cells no longer follow their normal pattern of controlled growth. In the absence or disregard of such regulation, resulting from changes in their genetic makeup, these errant cells acquire a growth advantage, expanding into precancerous clones. Over the last decade, many studies have revealed the relevance of genomic mutation in this process, be it by misreplication, environmental damage, or a deficiency in repairing endogenous and exogenous damage. Here, we discuss homologous recombination as another mechanism that can result in a loss of heterozygosity or genetic rearrangements. Some of these genetic alterations may play a primary role in carcinogenesis, but they are more likely to be involved in secondary and subsequent steps of carcinogenesis by which recessive oncogenic mutations are revealed. Patients, whose cells display an increased frequency of recombination, also have an elevated frequency of cancer, further supporting the link between recombination and carcinogenesis.
Figures

Similar articles
-
Role of homologous recombination in carcinogenesis.Exp Mol Pathol. 2003 Apr;74(2):94-105. doi: 10.1016/s0014-4800(03)00010-8. Exp Mol Pathol. 2003. PMID: 12710940 Review.
-
Homologous recombination as a mechanism of carcinogenesis.Biochim Biophys Acta. 2001 Mar 21;1471(3):M109-21. doi: 10.1016/s0304-419x(01)00018-x. Biochim Biophys Acta. 2001. PMID: 11250067 Review.
-
Mutagenic and recombinagenic effects of lamivudine and stavudine antiretrovirals in somatic cells of Drosophila melanogaster.Food Chem Toxicol. 2009 Mar;47(3):578-82. doi: 10.1016/j.fct.2008.12.014. Epub 2008 Dec 25. Food Chem Toxicol. 2009. PMID: 19138723
-
Genetic pathways of two types of gastric cancer.IARC Sci Publ. 2004;(157):327-49. IARC Sci Publ. 2004. PMID: 15055305 Review.
-
Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.Breast Cancer Res. 2014 Dec 5;16(6):475. doi: 10.1186/s13058-014-0475-x. Breast Cancer Res. 2014. PMID: 25475740 Free PMC article.
Cited by
-
Akt: a double-edged sword in cell proliferation and genome stability.J Oncol. 2012;2012:951724. doi: 10.1155/2012/951724. Epub 2012 Mar 15. J Oncol. 2012. PMID: 22481935 Free PMC article.
-
RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer.Cancer Epidemiol Biomarkers Prev. 2022 Dec 5;31(12):2136-2147. doi: 10.1158/1055-9965.EPI-22-0590. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 36129803 Free PMC article.
-
DNA damage response and prostate cancer: defects, regulation and therapeutic implications.Oncogene. 2015 May 28;34(22):2815-22. doi: 10.1038/onc.2014.238. Epub 2014 Aug 18. Oncogene. 2015. PMID: 25132269 Free PMC article. Review.
-
RecA requires two molecules of Mg2+ ions for its optimal strand exchange activity in vitro.Nucleic Acids Res. 2018 Mar 16;46(5):2548-2559. doi: 10.1093/nar/gky048. Nucleic Acids Res. 2018. PMID: 29390145 Free PMC article.
-
Human Hazard Assessment Using Drosophila Wing Spot Test as an Alternative In Vivo Model for Genotoxicity Testing-A Review.Int J Mol Sci. 2021 Sep 14;22(18):9932. doi: 10.3390/ijms22189932. Int J Mol Sci. 2021. PMID: 34576092 Free PMC article. Review.
References
-
- Todd R, Wong D T. Oncogenes. Anticancer Res. 1999;19(6A):4729–4746. - PubMed
-
- Macleod K. Tumor suppressor genes. Curr Opin Genet Dev. 2000;10(1):81–93. - PubMed
-
- Greller L D, Tobin F L, Poste G. Tumor heterogeneity and progression: conceptual foundations for modeling. Invasion Metastasis. 1996;16(4-5):177–208. - PubMed